Isovanillin-derived bis-hydrazones as dual cholinesterase and carbonic anhydrase inhibitors: synthesis, enzymatic profiling, and computational insights from molecular docking and dynamics
 
Yazarlar (5)
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı FUTURE MEDICINAL CHEMISTRY (Q3)
Dergi ISSN 1756-8919 Dergi Bilgileri (2026)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili Türkçe Basım Tarihi 02-2026
Cilt / Sayı / Sayfa 18 / 3 / 237–253 DOI 10.1080/17568919.2026.2617608
Makale Linki https://doi.org/10.1080/17568919.2026.2617608
UAK Araştırma Alanları
Tıbbi Biyokimya
Özet
AimsTo develop isovanillin-based bis-hydrazones as multitarget inhibitors of acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and human carbonic anhydrase I/II (hCA I/II).Materials & methodsTwelve bis-hydrazones (4a–4l) were synthesized in two steps and evaluated by spectrophotometric enzyme assays, Lineweaver–Burk kinetics, molecular docking, MM-GBSA, molecular dynamics simulations, and in silico ADME/Tox profiling.ResultsAll compounds showed nanomolar inhibition. Compound 4d was the most potent AChE/BChE inhibitor (KI = 10.46 and 3.56 nM), while 4a and 4j led the hCA I/II panel (KI = 3.46 and 16.12 nM). Docking, MM-GBSA, and molecular dynamics supported dual-site cholinesterase engagement and non-zinc, peripherally anchored hCA inhibition.ConclusionsIsovanillin-based bis-hydrazones, particularly 4d, 4a, and 4j, represent promising multitarget leads for cholinergic and h …
Anahtar Kelimeler
Isovanillin | bis-hydrazone derivatives | cholinesterase inhibition | carbonic anhydrase inhibition | molecular docking | ADMET profiling | molecular dynamics